| AMPARs | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors |
| AD | Alzheimer’s disease |
| SHANK | SH3 and ankyrin repeat domains protein |
| ASD | Autism spectrum disorders |
| AQPs | Aquaporins |
| BBB | Blood brain barrier |
| BMECs | Brain microvascular endothelial cells |
| BDNF | Brain-derived neurotrophic factor |
| Bral1 | Brain-specific hyaluronan-binding protein 1 |
| Bral2 | Brain-specific hyaluronan-binding protein 2 |
| Crtl1 | Cartilage-linking protein 1 |
| VAMP3 | Cellubrevin |
| CS | Chondroitin sulphate |
| CSPGs | Chondroitin sulphate proteoglycans |
| ChABC | Chondroitinase ABC |
| DAI | Diffuse axonal injury |
| GAG-GAG | Disaccharide polymers glucosaminoglycan- glucosaminoglycan |
| DLG4 | Discs Large MAGUK scaffold protein 4 |
| VAMP8 | Endobrevin |
| ECM | Extracellular matrix |
| Gal | Galactose |
| GalNAc | Galactose-N-acetylogalactosamine |
| GABA | Gamma-aminobutyric acid |
| GCS | Glasgow Coma Scale |
| GPI | Glycosylphosphatidylinositol |
| GlcA | Glucosamine |
| GAGs | Glucosaminoglycans |
| GlcNAc | Glucose N-acetyloglucosamine |
| GlcA-GlcNAc | Glucuronic acid–acetylogalactosamine |
| GlcA | Glucuronic acid |
| GKAP | Guanylate kinase-associated protein |
| GK | Guanylate kinase-like domain |
| HOMER | Homer protein |
| HAPLN-1, -3 and -4 | Hyaluronan and proteoglycan binding link protein |
| HAS | Hyaluronan synthase |
| HA | Hyaluronic acid (hyaluronan, |
| IdoA | Iduronic acid |
| MAGUK | Membrane-associated guanylate guanyl kinases |
| mGluR | Metabotropic glutamate receptor |
| MMPs | Metalloproteinases |
| VAMP5 | Myobrevin |
| NRXN1 | Neurexin 1 |
| NRXN2 | Neurexin 2 |
| NRXN3 | Neurexin 3 |
| NLGN1 | Neuroligin 1 |
| NLGN3 | Neuroligin 3 |
| NLGN4X, | Neuroligin 4, X-linked precursor |
| NLGN4Y | Neuroligin 4, Y-linked precursor |
| NLGN | Neuroligin |
| NMDA(R) | N-methyl-D-aspartate receptors |
| PD | Parkinson’s disease |
| PNNs | Perineuronal nets |
| PSD | Postsynaptic densities |
| PSD95/DLG4 | Postsynaptic density protein-95 |
| PAZ | Presynaptic active zone |
| NRXN1, NRXN2, NRXN3 | Neurexin 1,2,3 |
| PGs | Proteoglycans |
| SNAP | Soluble N-ethylmaleimide sensitive factor attachment protein |
| SNARE | Soluble N-ethylmaleimide sensitive factor attachment protein receptor |
| SVs | Synaptic vesicles |
| VAMP1/VAMP2; VAMP1/2 | Synaptobrevin ½ |
| Syp | Synaptophysin |
| SNAP-25 | Synaptosomal nerve-associated protein 25 |
| v-SNAREs | Vesicle-associated SNARE proteins |
| Syt-1 | Synaptotagmin 1 |
| t-SNAREs | Target-localized SNARE proteins |
| Tn-C | Tenascin-C |
| Tn-R | Tenascin-R |
| TJs | Tight junctions |
| Ti-VAMP | Tetanus-Insensitive VAMP |
| TIMP | Tissue inhibitor of metalloproteinase |
| TBI | Traumatic brain injury |
| Trk(R) | Tropomyosin receptor kinase B |
| VAMP4 | Vesicle-associated membrane protein 4 |
| VAMP | Vesicle-associated membrane protein |
| VAMP7 | Vesicle-associated membrane protein 7 |